Towarzystwo Funduszy Inwestycyjnych PZU SA’s AstraZeneca AZN Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.67M	Buy	8,972 +2,321	+35%	+$437K	0.47%	32
2026 Q1	$1.29M	Buy	6,651 +4,815	+262%	+$928K	0.43%	41
2025 Q4	$338K	Hold	1,836	–	–	0.09%	139
2025 Q3	$282K	Sell	1,836 -6,150	-77%	-$931K	0.07%	138
2025 Q2	$1.12M	Sell	7,986 -2,789	-26%	-$391K	0.31%	42
2025 Q1	$1.58M	Sell	10,775 -101	-0.9%	-$14.6K	0.54%	29
2024 Q4	$1.43M	Sell	10,876 -150	-1%	-$21K	0.47%	29
2024 Q3	$1.72M	Hold	11,026	–	–	0.62%	23
2024 Q2	$1.72M	Sell	11,026 -410	-4%	-$61.7K	0.64%	24
2024 Q1	$1.55M	Sell	11,436 -802	-7%	-$106K	0.66%	23
2023 Q4	$1.65M	Buy	+12,238	New	+$1.59M	0.76%	21
2021 Q3	$1.18M	Buy	9,818 +1,636	+20%	+$190K	1.41%	14
2021 Q2	$980K	Hold	8,182	–	–	1.16%	16
2021 Q1	$814K	Sell	8,182 -3,850	-32%	-$387K	1.18%	13
2020 Q4	$1.2M	Buy	+12,032	New	+$1.27M	1.25%	19

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's AZN Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its AstraZeneca (AZN) stake by 35% in Q2 2026, buying an estimated $437K and bringing the position to 8,972 shares worth $1.67M. The position accounts for 0.47% of the portfolio, ranked #32.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in AZN in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.72M in Q2 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Towarzystwo Funduszy Inwestycyjnych PZU SA held 8,972 shares of AstraZeneca worth $1.67M as of Q2 2026.
Towarzystwo Funduszy Inwestycyjnych PZU SA bought 2,321 AstraZeneca shares in Q2 2026, an estimated $437K.
AstraZeneca made up 0.47% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #32 holding.
Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in AstraZeneca in Q4 2020 and has held it in 15 quarters since.
Towarzystwo Funduszy Inwestycyjnych PZU SA's AstraZeneca position peaked at $1.72M in Q2 2024.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.